Viridian Therapeutics Inc. has approved the grant of non-qualified stock options to purchase a total of 88,300 shares of company common stock for four new employees. The stock options will have an exercise price equal to the closing price of Viridian's common stock on the grant date, November 3, 2025. The options vest over four years, with 25% vesting on the first anniversary of the employee's start date and the remainder vesting in 36 equal monthly installments, contingent on continued employment.